GLP-1 Agonists May Lower Cirrhosis, Liver Cancer Risk in Type 2 Diabetes Patients Study finds that individuals who took GLP-1 agonists for a long duration had a lower risk of going on to develop more severe forms of liver disease, including cirrhosis and liver cancer
You can use it twice daily for the best results
No significant relationship of dose-response was found in the dosage range of carnitine supplementation used in this study whose carnitine dosage was from 250 to 1,000 mg/day, indicating the lower limit of carnitine supplementation dosage, 250 mg/day, could be used as a suitable dosage
In a consumer study of 109 women after 28 days
Furthermore, its adverse effects are minimal, but may include abdominal pain, nausea, diarrhea and a fishy smell emanating for the patient (15)
Brightens the skin tone A more even tone under the eyes makes circles less visible